Literature DB >> 17999598

Progenitor cell characterization and location in the developing human liver.

John D Terrace1, Ian S Currie, David C Hay, Neil M Masson, Richard A Anderson, Stuart J Forbes, Rowan W Parks, James A Ross.   

Abstract

Tissue-derived stem cells may offer future liver disease therapies. The developing human liver provides an excellent model to examine normal hepatic progenitor cell maturation, but candidate populations are poorly characterized. We sought to identify putative progenitor phenotypes in first-trimester human liver, by characterizing the architectural relationship between developing epithelial, mesenchymal, and hematopoietic lineages. Bipotential hepatoblasts were identified by co-expression of hepatocytic (cytokeratin 18, albumin) and biliary(cytokeratin 19) specific markers and epithelial-specific E-cadherin. Restriction of dlk/pref-1 expression to hepatoblasts identifies this as a novel human marker allowing for hepatoblast sorting for in vitro analysis. Furthermore, the liver stem cell and haematopoietic marker Thy-1 was co-expressed with markers of hematopoietic (CD34) and mesenchymal (vimentin) lineage restriction on portal vein endothelium. Therefore, this structure may constitute a novel progenitor compartment with hemangioblast-like properties.

Entities:  

Mesh:

Year:  2007        PMID: 17999598     DOI: 10.1089/scd.2007.0016

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  14 in total

Review 1.  Thinking outside the liver: induced pluripotent stem cells for hepatic applications.

Authors:  Mekala Subba Rao; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 2.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

3.  KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development.

Authors:  Orit Goldman; Songyan Han; Marion Sourisseau; Marion Sourrisseau; Noelle Dziedzic; Wissam Hamou; Barbara Corneo; Sunita D'Souza; Thomas Sato; Darrell N Kotton; Karl-Dimiter Bissig; Tamara Kalir; Adam Jacobs; Todd Evans; Matthew J Evans; Valerie Gouon-Evans
Journal:  Cell Stem Cell       Date:  2013-06-06       Impact factor: 24.633

Review 4.  Liver bioengineering: current status and future perspectives.

Authors:  Christopher Booth; Tom Soker; Pedro Baptista; Christina L Ross; Shay Soker; Umar Farooq; Robert J Stratta; Giuseppe Orlando
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 5.  Liver development, regeneration, and carcinogenesis.

Authors:  Janet W C Kung; Ian S Currie; Stuart J Forbes; James A Ross
Journal:  J Biomed Biotechnol       Date:  2010-02-07

Review 6.  Derivation of Endodermal Progenitors From Pluripotent Stem Cells.

Authors:  Laertis Ikonomou; Darrell N Kotton
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

Review 7.  Stem cell differentiation and human liver disease.

Authors:  Wen-Li Zhou; Claire N Medine; Liang Zhu; David C Hay
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

Review 8.  Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate.

Authors:  Hei Sook Sul
Journal:  Mol Endocrinol       Date:  2009-06-18

9.  Polarisation and functional characterisation of hepatocytes derived from human embryonic and mesenchymal stem cells.

Authors:  Anwar Azad Palakkan; Robert Drummond; Richard Alexander Anderson; Sebastian Greenhough; Kumary Tv; David Colin Hay; James Alexander Ross
Journal:  Biomed Rep       Date:  2015-06-18

10.  Three-dimensional reconstructions of intrahepatic bile duct tubulogenesis in human liver.

Authors:  Peter S Vestentoft; Peter Jelnes; Branden M Hopkinson; Ben Vainer; Kjeld Møllgård; Bjørn Quistorff; Hanne C Bisgaard
Journal:  BMC Dev Biol       Date:  2011-09-26       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.